Startups
Venus Remedies
Edit

Venus Remedies

Trusted
http://www.venusremedies.com/
Last activity: 23.05.2026
Active
Categories: AdTechManufacturing
We are a fully integrated company, known for R&D initiatives, world class manufacturing facilities, rich IP Wealth, strong marketing network worldwide and highly efficient professionals.
Website visits
7.5K /mo.
Mentions
12

Overview

Employees
501-1000
Founded date
1989

Mentions in press and media 12

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Mar 7, 2025Medivir’s CEO to BioStock: “I am proud to see our research contribute to a global solution”Medivir’s CEO to BioStock: “I am proud to see our research contribute to a global solution” Fri, Mar 07, 2025 08:40 CET Report this content Antibiotic resistance is a growing global crisis, increasing the urgency for effective treatments. W...
Nov 9, 2024Venus Remedies and Apollo Hospitals: Pioneering Healthcare Expansion in IndiaIn the ever-evolving landscape of healthcare, two companies are making significant strides: Venus Remedies and Apollo Hospitals. Both are not just expanding their footprints but are also reshaping the healthcare narrative in India. Their re...
Nov 5, 2024Venus Remedies secures Malaysian PIC/S Certification for pre-filled syringe facilityVenus Remedies Limited has received Good Manufacturing Practices (GMP) approval with PIC/S accreditation from Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) for its pre-filled syringe facility in Baddi, India. The certification...
Jul 15, 2021Venus Remedies Enters Consumer Healthcare Business With R3SET LaunchTo introduce disruptive products overthe next fiveyears, covering key segments like pain management, gastro-enterology, hygiene, stress management, vitamins, and supplements Offers holistic pain management solution called R3SET, which ensur...
Feb 24, 2015Budget Expectation from Mr Pawan Chaudhary, CMD, Venus RemediesIndia Quote of Mr Pawan Chaudhary, Chairman and Managing Director, Venus Remedies on his expectations from the 2015-16 Union Budget: The Union Finance Minister should take his government’s “Make in India” campaign to the next level by takin...
Feb 9, 2015Venus Remedies Bags Indian Patent for VancoplusChandigarh, Punjab, India The novel antibiotic adjuvant entity is highly effective against drug-resistant infections, different resistance mechanisms which no other existing therapeutic options available in the market are able to tackle Van...
Nov 11, 2014Venus Strengthens Portfolio in Swiss Market with Marketing Authorisation for MeropenemChandigarh, Punjab, India Gets approval from Swiss drug authority Swissmedic through its German subsidiary Venus Pharma GmbH for meropenem 500 mg, 1 g injections With plans to launch the product early next year through its partner Swiss Pha...
Sep 25, 2014Venus Forays Into Singapore’s Topical Pain Management Market with Marketing Approval, Patent for TroisChandigarh, Punjab, India Company holding talks with various pharmaceutical firms for tie-ups Trois has a huge potential in Singapore, where 10% people are diagnosed with arthritis, 73.4% of the office workers suffer from musculoskeletal di...
Sep 8, 2014Venus Ties Up with Mylan for Marketing Meropenem in Three European CountriesChandigarh, Punjab, India The distribution-cum-outlicensing agreement between Venus Pharma GmbH, Germany and Mylan will enable Venus Remedies to market meropenem in Denmark, Sweden and Finland for five years While the drug will be manufactu...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Venus Remedies

When was Venus Remedies founded?

Venus Remedies was founded in 1989.

What has the press written about Venus Remedies?

Parsers VC has collected 12 articles mentioning Venus Remedies, among them “Medivir’s CEO to BioStock: “I am proud to see our research contribute to a global solution”” (Mar 7, 2025) and “Venus Remedies and Apollo Hospitals: Pioneering Healthcare Expansion in India” (Nov 9, 2024).

Is Venus Remedies still active?

Yes, Venus Remedies is active; its latest activity on Parsers VC dates from May 23, 2026.